DNER and head and neck squamous cell carcinoma: While our work focused on HPV-negative HNSCC, our findings suggest increased enhancer activity on genes involved in lipid and cholesterol metabolism, MAPK signaling, and WNT-β-​catenin signaling may serve as a general mechanism of baseline resistance to BET inhibition.